Abstract:Keratin-based biomaterials represent an attractive opportunity in the fields of wound healing and tissue regeneration, not only for their chemical and physical properties, but also for their ability to act as a delivery system for a variety of payloads. Importantly, keratins are the only natural biomaterial that is not targeted by specific tissue turnover-related enzymes, giving it potential stability advantages and greater control over degradation after implantation. However, in-situ polymerization chemistry … Show more
“…Hydrogels and scaffolds use a range of natural and synthetic materials and biopolymers to achieve bone regeneration [ 56 , 57 ]. Natural materials include proteins, such as collagen, gelatin, laminin, keratin, elastin, fibroin, fibrin, heparin; or polysaccharides such as hyaluronan, chitosan and alginate, while those with microbial activity including cellulose, gellan gum and dextran [ 58 , 59 , 60 , 61 , 62 , 63 ]. Synthetic biopolymers include poly(ethylene glycol) (PEG), polyacrylamide (PAM), plyvinyl alcohol (PVA), poly lactic acid to name a few [ 57 , 58 , 64 , 65 ].…”
Section: Skeletal Tissue Regeneration—advancements Over the Last Dmentioning
confidence: 99%
“…The natural and synthetic materials are fabricated into a range of structures including but not limited to injectable hydrogels, microbeads, nanogels, hydrogel fibers, biofilms, membranes, solid porous scaffolds or sponges. These scaffolds are prepared by microfluidics, in situ polymerization, electrostatic droplet extrusion, emulsification and coaxial air jetting, physical and chemical crosslinking, electrospinning, solvent casting and particulate leaching, gas-foaming, powder compaction, emulsion freeze-drying, thermal phase separation, laser sintering, stereolitography, and 3D printing [ 56 , 59 , 60 ].…”
Section: Skeletal Tissue Regeneration—advancements Over the Last Dmentioning
There has been an escalation in reports over the last decade examining the efficacy of bone marrow derived mesenchymal stem/stromal cells (BMSC) in bone tissue engineering and regenerative medicine-based applications. The multipotent differentiation potential, myelosupportive capacity, anti-inflammatory and immune-modulatory properties of BMSC underpins their versatile nature as therapeutic agents. This review addresses the current limitations and challenges of exogenous autologous and allogeneic BMSC based regenerative skeletal therapies in combination with bioactive molecules, cellular derivatives, genetic manipulation, biocompatible hydrogels, solid and composite scaffolds. The review highlights the current approaches and recent developments in utilizing endogenous BMSC activation or exogenous BMSC for the repair of long bone and vertebrae fractures due to osteoporosis or trauma. Current advances employing BMSC based therapies for bone regeneration of craniofacial defects is also discussed. Moreover, this review discusses the latest developments utilizing BMSC therapies in the preclinical and clinical settings, including the treatment of bone related diseases such as Osteogenesis Imperfecta.
“…Hydrogels and scaffolds use a range of natural and synthetic materials and biopolymers to achieve bone regeneration [ 56 , 57 ]. Natural materials include proteins, such as collagen, gelatin, laminin, keratin, elastin, fibroin, fibrin, heparin; or polysaccharides such as hyaluronan, chitosan and alginate, while those with microbial activity including cellulose, gellan gum and dextran [ 58 , 59 , 60 , 61 , 62 , 63 ]. Synthetic biopolymers include poly(ethylene glycol) (PEG), polyacrylamide (PAM), plyvinyl alcohol (PVA), poly lactic acid to name a few [ 57 , 58 , 64 , 65 ].…”
Section: Skeletal Tissue Regeneration—advancements Over the Last Dmentioning
confidence: 99%
“…The natural and synthetic materials are fabricated into a range of structures including but not limited to injectable hydrogels, microbeads, nanogels, hydrogel fibers, biofilms, membranes, solid porous scaffolds or sponges. These scaffolds are prepared by microfluidics, in situ polymerization, electrostatic droplet extrusion, emulsification and coaxial air jetting, physical and chemical crosslinking, electrospinning, solvent casting and particulate leaching, gas-foaming, powder compaction, emulsion freeze-drying, thermal phase separation, laser sintering, stereolitography, and 3D printing [ 56 , 59 , 60 ].…”
Section: Skeletal Tissue Regeneration—advancements Over the Last Dmentioning
There has been an escalation in reports over the last decade examining the efficacy of bone marrow derived mesenchymal stem/stromal cells (BMSC) in bone tissue engineering and regenerative medicine-based applications. The multipotent differentiation potential, myelosupportive capacity, anti-inflammatory and immune-modulatory properties of BMSC underpins their versatile nature as therapeutic agents. This review addresses the current limitations and challenges of exogenous autologous and allogeneic BMSC based regenerative skeletal therapies in combination with bioactive molecules, cellular derivatives, genetic manipulation, biocompatible hydrogels, solid and composite scaffolds. The review highlights the current approaches and recent developments in utilizing endogenous BMSC activation or exogenous BMSC for the repair of long bone and vertebrae fractures due to osteoporosis or trauma. Current advances employing BMSC based therapies for bone regeneration of craniofacial defects is also discussed. Moreover, this review discusses the latest developments utilizing BMSC therapies in the preclinical and clinical settings, including the treatment of bone related diseases such as Osteogenesis Imperfecta.
“…[6] Nevertheless, the most sophisticated designs with high porosity, [7] surface/volume ratio, [8] anisotropic properties, [9] or DOI: 10.1002/adma.202304659 surface topography [10] are often created with synthetic polymers or biologically derived polysaccharides. Protein-based microparticles cover a small niche, with most advanced research focusing on collagen, [11] keratin, [12] elastin-like polypeptides (ELPs), [13] and the well-known gelatin. [14] Proteins are considered emerging biomaterials for biotechnology and bioengineering, boosting cell-material interactions and cell-cell communications.…”
There is a demand to design microparticles holding surface topographies while presenting inherent bioactive cues for applications in the biomedical and biotechnological fields. Using the pool of proteins present in human‐derived platelet lysates (PL), it is reported the production of protein‐based microparticles via a simple and cost‐effective method, exploring the prone redox behavior of cysteine (‐SH) amino acid residues. The forced formation of new intermolecular disulfide bonds results in the precipitation of the proteins as spherical, pompon‐like microparticles with adjustable sizes (15‐50 μm in diameter) and surface topography consisting of grooves and ridges. These PL microparticles exhibit extraordinary cytocompatibility, allowing cell‐guided micro‐aggregates to form, while also working as injectable systems for cell support. Early studies also suggests that the surface topography provided by these PL microparticles can support osteogenic behavior. Consequently, these PL microparticles may find use to create live tissues via bottom‐up procedures or injectable tissue‐defect fillers, particularly for bone regeneration, with the prospect of working under xeno‐free conditions.This article is protected by copyright. All rights reserved
“…Additionally, keratins contain cell adhesion motifs similar in structure to extracellular matrix proteins (such as collagen or fibronectin), arginine-glycine-aspartate (RGD) and leucine-aspartate-valine (LDV), which can support cell attachment and proliferation [ 5 ]. These unique structures and biological properties make keratin the focus of the biomedical field, including wound dressing, tissue engineering and drug delivery [ 6 , 7 , 8 , 9 , 10 , 11 , 12 ]. Nevertheless, the shortcomings of brittleness, poor mechanical properties and processing properties limit the practical use of keratin [ 13 , 14 ].…”
The main core of wound treatment is cell growth and anti-infection. To accelerate the proliferation of fibroblasts in the wound and prevent wound infections, various strategies have been tried. It remains a challenge to obtain good cell proliferation and antibacterial effects. Here, human hair kerateine (HHK)/poly(ethylene oxide) (PEO)/poly(vinyl alcohol) (PVA) nanofibers were prepared using cysteine-rich HHK, and then, silver nanoparticles (AgNPs) were in situ anchored in the sulfur-containing amino acid residues of HHK. After the ultrasonic degradation test, HHK/PEO/PVA nanofibrous mats treated with 0.005-M silver nitrate were selected due to their relatively complete structures. It was observed by TEM-EDS that the sulfur-containing amino acids in HHK were the main anchor points of AgNPs. The results of FTIR, XRD and the thermal analysis suggested that the hydrogen bonds between PEO and PVA were broken by HHK and, further, by AgNPs. AgNPs could act as a catalyst to promote the thermal degradation reaction of PVA, PEO and HHK, which was beneficial for silver recycling and medical waste treatment. The antibacterial properties of AgNP-HHK/PEO/PVA nanofibers were examined by the disk diffusion method, and it was observed that they had potential antibacterial capability against Gram-positive bacteria, Gram-negative bacteria and fungi. In addition, HHK in the nanofibrous mats significantly improved the cell proliferation of NIH3T3 cells. These results illustrated that the AgNP-HHK/PEO/PVA nanofibrous mats exhibited excellent antibacterial activity and the ability to promote the proliferation of fibroblasts, reaching our target applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.